Literature DB >> 29337291

Realization of a half-metallic state on bilayer WSe2 using doping transition metals (Cr, Mn, Fe, Co, Ni) in its interlayer.

Guang Yang1, Yanmin Yang, Hongran Ma, Xiujuan Mao, Congcong Li, Jie Li, Qiang Zhang, Zhidong Zhang, Fuxing Yin, Jia Li.   

Abstract

The structural, electronic and magnetic properties of Cr, Mn, Fe, Co and Ni-doped bilayer WSe2 are predicted by using first principles calculations. The doped transition-metal (TM) atoms show a covalent-binding with the nearest Se atoms. The calculated electronic structures reveal that the TM Cr, Mn, Fe and Co-doped bilayer WSe2 exhibits a half-metallic character with a 100% spin polarization at the Fermi level, and the reason is ascribed to the strong hybridization peak between the transition metals and the parent W and Se atoms. The Ni-doped bilayer WSe2 is still a semiconductor with nonmagnetism. The Fe-doped system has a robust stability of half-metallicity because there are three connected states peak spanning the Fermi level. The doping of Cr, Mn, Fe and Co atoms leads to a prominent total magnetism (0.93-3.65 [Formula: see text] moment per unit cell), and an induced ∼0.3 [Formula: see text] moment in parent W atoms is found in addition to the main contribution of TM atomic magnetism (0.71-3.33 [Formula: see text] moment per atom). The predicted Cr, Mn, Fe and Co-doped bilayer WSe2 should be the candidate materials for spintronic devices due to their magnetic and half-metallic nature.

Entities:  

Year:  2018        PMID: 29337291     DOI: 10.1088/1361-6528/aaa80d

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  1 in total

1.  Electronic and magnetic properties of a black phosphorene/Tl2S heterostructure with transition metal atom intercalation: a first-principles study.

Authors:  Yusheng Wang; Xiaoyan Song; Nahong Song; Tianjie Zhang; Xiaohui Yang; Weifen Jiang; Jianjun Wang
Journal:  RSC Adv       Date:  2019-06-20       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.